Health Trials

Sentio Systematic Evaluation

ConditionsHearing Loss, Bilateral or UnilateralHearing Loss, ConductiveHearing Loss, Mixed Conductive-SensorineuralSingle Sided DeafnessHearing LossHearing-ImpairmentHearing Aid
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorOticon Medical

About this trial

The study is designed as an international, multi-center, single-armed, non-interventional/observational study including subjects who has received or are planned to receive the Sentio system as part of normal clinical practice.

Eligibility criteria

Qualifiers

Subject who is scheduled for or have undergone Sentio implantation in clinical practice.

Subject who has consented to participation or are covered by consent waiver.

Disqualifiers

Subjects enrolled in other clinical investigations leading to their Sentio implantation and subsequent follow-up deviating substantially from clinical practice

Trial design

Treatments tested in this trial

  • Transcutaneous bone conduction hearing system

Treatment groups

100 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Oticon Medical

Lead sponsor

Source ClinicalTrials.gov